Mont-Saint-Guibert, Belgium – Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the company plans to participate at the following conferences in February 2021:
CAR-TCR Digital Summit Europe
Date: Wednesday, February 17, 2021
Time: 2:00 p.m. GMT / 3 p.m. CET
SVB Leerink Partners Global Healthcare Conference
Date: Thursday, February 25, 2021
Time: 4:20 p.m. – 4:50 p.m. ET / 10:20 p.m. – 10:50 p.m. CET
Webcast: A live and archived webcast of the presentation will be available in the Events section of the Celyad Oncology website
